Skip to main content
Watch Insiders
Market intelligence
RNTXSector not reported

Rein Therapeutics, Inc. insider activity

In the last 90 days, 2 corporate insiders purchased $74,559 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$74,559
Corporate buyers
2
Latest transaction
May 27, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 27, 2026Rickenbach Josef H VonDirectorOpen Market Purchase47,060$1.05$49,559
Apr 30, 2026James Brian WindsorSee RemarksOpen Market Purchase25,000$1.00$25,000